drugset / Trial / NCT03202550

Oral Sedation During Cervical Dilator Placement

NCT03202550

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This will be a randomized, double-blind, placebo-controlled trial involving 2 arms. It will be comparing the effects of placebo compared to 1 mg oral lorazepam/5 mg oral oxycodone on pain scores during cervical dilator placement prior to dilation and evacuation (D\&E).

Timeline

Start
2017-06-28
Primary completion
2019-05-28
Completion
2019-05-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lorazepam Small molecule 1 mg Oral
Comparator Oxycodone Other / unclassified 5 mg Oral

Indications

No indication recorded.